Chordia Therapeutics (190A) · RiskFirst stated

Risk of R&D activity disruptions caused by accidents and natural disasters at open labs

First written in FY2024. . Latest entry: FY2024.

1entries

1years

0from disclosures

How it moved

Same theme, other companies

Risk of Research and Development Facility and Activity Disruption Due to Natural Disasters and AccidentsA theme 10 companies write about · 10 as a headwind · 0 as a tailwind

1 other company's latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.

Full recordFilings, disclosures and news, newest first

FY2024First statedAnnual report
「Because we operate in an open-laboratory environment, a fire, environmental contamination or leakage accident caused by any number of factors could result in the interruption or suspension of research and development activities, significant losses such as damages, or other serious consequences.」
The company identified the risks of fire and leakage accidents associated with using the open laboratories at Shonan iPark, as well as the suspension of research facilities and operations due to earthquakes, flooding and other events.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next

Chordia Therapeutics's next results are scheduled for 2026-10-15. Read the earnings preview

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.